Make a Gift
College of Health Sciences
Healthcare Professionals
Volunteering
MyChart Login
Clinical Trials
Career Opportunities
Contact Us
≡
Medical Services
Find a Provider
Patients & Visitors
Classes & Events
Clinical Trials
Contact a Patient
Dining
Donate Blood
Parking
Patient Feedback
Pay Bills Online
Pricing Transparency
Visiting Hours
MyChart Login ›
Report Sexual Misconduct ›
Locations
News & Blog
News & Stories
Live Well Blog
Live Well Magazine
Webinars
Subscribe to Newsletter
Coronavirus FAQ
Events
About Us
About UCI Health
340B Program
Classes & Events
Community Health
Compliance
Contact Us
Giving
Human Resources
News
Nondiscrimination
Planning Administration
Publications
Quality & Safety
Virtual Tour
Volunteering
Site Search
Site Search
Clinical Trials
›
Cancer Clinical Trial
›
Pancreas
›
A phase 3, randomized, double-blind, placebo-controlled, multicenter study of pegylated recombinant human hyaluronidase (PEGPH20) in combination with nab-paclitaxel plus gemcitabine compared with placebo plus nab-paclitaxel and gemcitabine in subjects with hyaluronan-high stage IV previously untreated pancreatic ductal adenocarcinoma
Print
A
A
A